HALO logo
halo search icon
Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc.
SUPN · NAS

Supernus Pharmaceuticals, Inc.

US$49.38

Price Arrow0.69 (1.42%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusConsensus CheapHALO AllHammer BullishHammer Bullish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Supernus Pharmaceuticals, Inc. Overview

SUPN Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Strong

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Weak

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Strong

Balance Sheet

Very Weak

About SUPN

icon

Telephone

1.301.838.2500

icon

Address

9715 Key West Avenue, Rockville, MD 20850

Description

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005, and is headquartered in Rockville, MD.

SUPN Price Chart

Key Stats

Market Cap

US$2.83B

PE

16.40

EV/EBITDA

45.9

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 30.83 - 59.68

Trade Value (12mth)

US$8,645,362.00

1 week

-1.5%

1 month

-3.18%

YTD

-1.58%

1 year

51.97%

All time high

61.25

Key Fundamentals

EPS 3 yr Growth

-160.40%

EBITDA Margin

7.60%

Operating Cashflow

$47m

Free Cash Flow Return

4.40%

ROIC

-3.60%

Interest Coverage

0.00

Quick Ratio

1.70

Other Data

Shares Outstanding (Fully Diluted)

58m

HALO Sector

Healthcare

Next Company Report Date

02-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

SUPN Announcements

Latest Announcements

DateAnnouncements
21 May 26
21 May 26
06 May 26
06 May 26
06 May 26

SUPN Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock0.021.34-0.68locklocklock
EPS (Fully Diluted)
$locklocklocklock0.021.32-0.68locklocklock
Growth
%locklocklocklock-97.95,462.7-150.9locklocklock
PE
Xlocklocklocklock1,221.127.416.4locklocklock
EV/EBITDA
Xlocklocklocklock13.811.145.9locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Supernus Pharmaceuticals, Inc. (SUPN:NAS)?
Halo FAQ
The current share price of Supernus Pharmaceuticals, Inc. (SUPN:NAS) is USD$49.38.
What is the 52-week high share price for Supernus Pharmaceuticals, Inc. (SUPN:NAS)?
Halo FAQ
The 52-week high share price for Supernus Pharmaceuticals, Inc. (SUPN:NAS) is USD$59.68.
What is the 52-week low share price for Supernus Pharmaceuticals, Inc. (SUPN:NAS)?
Halo FAQ
The 52-week low share price for Supernus Pharmaceuticals, Inc. (SUPN:NAS) is USD$30.83.
What is the dividend yield for Supernus Pharmaceuticals, Inc. (SUPN:NAS)?
Halo FAQ
Supernus Pharmaceuticals, Inc. (SUPN:NAS) does not pay a dividend.
What was Supernus Pharmaceuticals, Inc. (SUPN:NAS) last dividend payment?
Halo FAQ
Supernus Pharmaceuticals, Inc. (SUPN:NAS) does not pay a dividend.
What is the franking level for Supernus Pharmaceuticals, Inc. (SUPN:NAS)?
Halo FAQ
Supernus Pharmaceuticals, Inc. (SUPN:NAS) has a franking level of 0.00%.
In which sector is Supernus Pharmaceuticals, Inc. (SUPN:NAS) classified?
Halo FAQ
Supernus Pharmaceuticals, Inc. (SUPN:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Supernus Pharmaceuticals, Inc. (SUPN:NAS)?
Halo FAQ
The current P/E ratio for Supernus Pharmaceuticals, Inc. (SUPN:NAS) is 16.40.

See beyond the curve.

One solution for research, investing and portfolio management.